CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test
Components: CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CLN8 Gene Ceroid lipofuscinosis neuronal type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 8.
Test Details
The CLN8 gene is associated with a rare neurodegenerative disorder called Ceroid Lipofuscinosis Neuronal Type 8 (CLN8). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain and other organs. CLN8 gene mutations can lead to a loss of function of the CLN8 protein, which is involved in the transport and processing of lipids within cells.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It can be used to identify mutations or variations in the CLN8 gene and other genes associated with neurodegenerative disorders. NGS testing is often used when a specific genetic disorder is suspected but the underlying genetic cause is unknown or when multiple genes need to be analyzed simultaneously.
The CLN8 NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the CLN8 gene and potentially other relevant genes. The resulting sequence data is then analyzed to identify any mutations or variations in the CLN8 gene that may be associated with the neurodegenerative disorder. This genetic test can help confirm a diagnosis of CLN8-related neuronal ceroid lipofuscinosis and provide information about the specific genetic mutation present. It can also be used for carrier testing and prenatal testing in families with a known CLN8 gene mutation.
It is important to note that genetic testing for CLN8 and other neurodegenerative disorders should be performed and interpreted by qualified healthcare professionals with expertise in genetics and genetic counseling. The results of genetic testing can have significant implications for individuals and their families, and genetic counseling is often recommended to discuss the implications and potential next steps.
Test Name | CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLN8 Gene Ceroid lipofuscinosis neuronal type 8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 8 |
Test Details |
The CLN8 gene is associated with a rare neurodegenerative disorder called Ceroid Lipofuscinosis Neuronal Type 8 (CLN8). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain and other organs. CLN8 gene mutations can lead to a loss of function of the CLN8 protein, which is involved in the transport and processing of lipids within cells. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It can be used to identify mutations or variations in the CLN8 gene and other genes associated with neurodegenerative disorders. NGS testing is often used when a specific genetic disorder is suspected but the underlying genetic cause is unknown or when multiple genes need to be analyzed simultaneously. The CLN8 NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the CLN8 gene and potentially other relevant genes. The resulting sequence data is then analyzed to identify any mutations or variations in the CLN8 gene that may be associated with the neurodegenerative disorder. This genetic test can help confirm a diagnosis of CLN8-related neuronal ceroid lipofuscinosis and provide information about the specific genetic mutation present. It can also be used for carrier testing and prenatal testing in families with a known CLN8 gene mutation. It is important to note that genetic testing for CLN8 and other neurodegenerative disorders should be performed and interpreted by qualified healthcare professionals with expertise in genetics and genetic counseling. The results of genetic testing can have significant implications for individuals and their families, and genetic counseling is often recommended to discuss the implications and potential next steps. |